This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline to 1 week and two weeks follow in motor symptoms as assessed with sensor recordings (OPAL system)
Timeframe: Baseline (t0), at 1 week (t1), at 2 weeks (t2)